| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 11 |
Theravance Biopharma Q3 2024 Earnings Preview
|
| Nov 11 |
Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts?
|
| Nov 11 |
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance
|
| Nov 8 |
5 Small Drug Stocks to Buy as Trump Gets Re-Elected
|
| Oct 24 |
Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024
|
| Oct 18 |
Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease
|
| Sep 10 |
Seth Klarman's Complete Exit from Theravance Biopharma Inc
|
| Sep 6 |
Why Is Madrigal (MDGL) Up 1% Since Last Earnings Report?
|
| Sep 6 |
Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation
|
